Savior Lifetec

4167 · TWO · Healthcare / Biotechnology

19.15TWD+0.15 (+0.79%)

Price History

Full chart

Market Stats

Previous Close19.00

Open19.20

Day Range19.05 – 19.45

52-Week Range14.75 – 21.20

Volume983.58K

Market Cap6.48B

P/E (TTM)6.33

Forward P/E0.00

EPS3.09

Dividend Yield4.12%

Beta0.13

50-Day Avg19.15

200-Day Avg18.73

About

Savior Lifetec Corporation engages in the research, development, design, manufacture, and sale of carbapenem generics in the Americas, Asia, Taiwan, Europe, and internationally. The company offers injection generics, controlled-release generics, the development of new dosage forms and drugs, and the APIs, excipients, intermediates, and dosage forms. It also provides medicine manufacturer technology and services. In addition, the company sells antibacterial raw materials and injectables. Savior Lifetec Corporation was founded in 1993 and is headquartered in Tainan City, Taiwan.

Company Details

SectorHealthcare
IndustryBiotechnology
CEOMr. Chia-Chu Chou
Employees0
HeadquartersNo. 1, Nanke 6th Road, Tainan City, Taiwan, 744094, Taiwan
Websitehttps://www.saviorlifetec.com.tw

Leadership

Mr. Chia-Chu ChouRepresentative Director & Assistant VP · b. 1982
Mr. Chih-Fang ChenPresident & Managerial Officer
Kuo-Wei LinFinancial Officer & Accounting Supervisor
Fang Zhen XuHead of Internal Audit

Financials

Income Statement

Currency: TWD	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	786.34M	837.82M	1.00B	1.02B	1.12B	1.53B	1.62B	1.10B	1.32B	1.83B	1.74B	1.27B	1.05B	1.22B	1.20B
Growth (%)	-	+6.55%	+19.43%	+1.82%	+9.99%	+36.72%	+5.61%	-31.73%	+19.37%	+38.56%	-4.57%	-27.41%	-17.02%	+15.91%	-1.28%
Cost of Revenue	924.59M	1.09B	928.48M	1.00B	1.20B	1.35B	1.18B	1.18B	967.70M	1.27B	1.44B	1.13B	829.33M	870.57M	778.28M
Gross Profit	-138.26M	-247.76M	72.16M	18.58M	-82.40M	186.90M	440.34M	-70.49M	350.99M	558.64M	307.87M	130.99M	220.95M	346.76M	423.41M
Gross Margin	-17.58%	-29.57%	7.21%	1.82%	-7.35%	12.20%	27.21%	-6.38%	26.62%	30.57%	17.66%	10.35%	21.04%	28.49%	35.23%
Operating Expense	159.21M	197.00M	294.86M	351.36M	380.93M	369.95M	334.35M	287.34M	316.81M	271.59M	283.19M	78.99M	223.37M	227.86M	225.16M
Operating Income	-297.47M	-444.76M	-222.70M	-332.78M	-463.33M	-183.05M	105.99M	-357.83M	34.18M	287.05M	24.68M	52.00M	-2.42M	118.90M	198.24M
Operating Margin	-37.83%	-53.09%	-22.26%	-32.66%	-41.35%	-11.95%	6.55%	-32.39%	2.59%	15.71%	1.42%	4.11%	-0.23%	9.77%	16.50%
EBITDA	-113.47M	-303.87M	-93.84M	-171.60M	-260.47M	35.55M	251.95M	-143.75M	247.50M	508.65M	263.33M	260.73M	217.63M	313.85M	631.60M
EBITDA Margin	-14.43%	-36.27%	-9.38%	-16.84%	-23.24%	2.32%	15.57%	-13.01%	18.77%	27.84%	15.10%	20.60%	20.72%	25.78%	52.56%
Net Income	-234.56M	-452.83M	-228.70M	-355.79M	-493.79M	-207.70M	22.27M	-359.55M	-44.05M	250.94M	-4.76M	20.62M	30.03M	182.38M	537.45M
Net Income Margin	-29.83%	-54.05%	-22.86%	-34.92%	-44.06%	-13.56%	1.38%	-32.55%	-3.34%	13.73%	-0.27%	1.63%	2.86%	14.98%	44.72%
R&D	93.64M	108.33M	208.32M	256.89M	255.69M	242.67M	215.80M	142.84M	187.69M	179.13M	167.27M	119.12M	110.95M	75.11M	67.18M
R&D as % of Total Revenue	11.91%	12.93%	20.82%	25.21%	22.82%	15.84%	13.34%	12.93%	14.23%	9.80%	9.59%	9.41%	10.56%	6.17%	5.59%
Interest Expense	13.46M	21.81M	6.15M	18.44M	29.96M	35.92M	26.90M	17.54M	31.95M	24.22M	17.86M	15.69M	9.87M	7.48M	5.43M
Interest Expense % of Total Revenue	1.71%	2.60%	0.61%	1.81%	2.67%	2.34%	1.66%	1.59%	2.42%	1.33%	1.02%	1.24%	0.94%	0.61%	0.45%

Balance Sheet

Currency: TWD	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	2.33B	2.38B	2.76B	3.13B	3.25B	3.44B	3.95B	3.53B	4.03B	4.84B	4.54B	4.41B	3.82B	4.38B	4.18B
Total Liabilities	1.02B	1.10B	1.37B	1.84B	1.65B	1.32B	1.78B	1.67B	1.82B	1.51B	1.23B	1.04B	457.96M	860.02M	403.30M
Total Equity	1.31B	1.27B	1.39B	1.29B	1.59B	2.12B	2.16B	1.86B	2.21B	3.33B	3.31B	3.35B	3.35B	3.51B	3.78B
Cash	220.70M	249.08M	69.72M	218.03M	278.09M	476.57M	674.01M	383.98M	559.03M	682.59M	491.41M	1.09B	1.08B	1.36B	823.40M
Total Debt	638.35M	726.59M	480.79M	1.32B	1.27B	670.46M	944.88M	1.10B	1.45B	958.96M	951.25M	803.27M	270.38M	-	-
Net Debt	417.64M	477.51M	411.06M	1.11B	994.79M	193.89M	270.87M	714.13M	895.78M	276.37M	459.84M	-282.73M	-812.54M	-	-

Cash Flow

Currency: TWD	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-458.82M	-227.59M	-85.39M	-92.41M	-415.82M	-76.09M	260.89M	-189.84M	156.40M	91.25M	-168.34M	581.77M	387.95M	518.38M	-21.04M
Investing Cash Flow	-	-	-	-	-288.70M	-72.15M	-384.93M	-2.43M	-145.75M	-311.82M	18.53M	20.29M	-	-	-
Financing Cash Flow	844.62M	592.53M	523.64M	586.85M	764.58M	346.73M	321.49M	-97.76M	164.40M	344.13M	-41.37M	-7.48M	-572.22M	-	-
Capital Expenditure	292.39M	315.92M	580.10M	394.83M	279.34M	78.04M	131.88M	204.65M	199.26M	216.52M	95.61M	34.17M	17.88M	118.46M	143.23M
Free Cash Flow	-751.21M	-543.51M	-665.49M	-487.24M	-695.15M	-154.13M	129.01M	-394.50M	-42.86M	-125.27M	-263.94M	547.60M	370.07M	399.92M	-164.28M
Dividends Paid	-	-	-	-	-	-	-	40.00M	40.00M	40.00M	40.00M	-	32.75M	27.03M	126.96M
FCF to OCF	163.73%	238.81%	779.36%	527.26%	167.18%	202.56%	49.45%	207.80%	-27.41%	-137.28%	156.79%	94.13%	95.39%	77.15%	780.74%
Dividend Paid to FCF	-	-	-	-	-	-	-	-10.14%	-93.32%	-31.93%	-15.15%	-	8.85%	6.76%	-77.29%

Earnings

Report Date	Nov 12, 2015	Mar 30, 2016	Mar 28, 2017	May 8, 2017	Aug 10, 2017	Nov 10, 2017	Mar 29, 2018	May 8, 2018	Aug 9, 2018	Nov 9, 2018	Mar 20, 2020	May 3, 2020	Aug 13, 2020	Nov 4, 2020	Mar 18, 2021	May 13, 2021	Aug 5, 2021	Nov 3, 2021	Mar 20, 2022	May 5, 2022	Nov 10, 2022	Mar 2, 2023
EPS Estimate	-0.62	-0.66	0.05	0.08	0.12	0.04	0.30	-0.11	-0.03	0.21	0.05	0.28	0.38	0.27	0.28	0.28	0.26	0.24	-	-	-	-
EPS Actual	-0.54	-0.70	0.08	0.04	0.16	0.06	-0.22	-0.36	-0.19	-0.35	0.16	0.28	0.07	0.13	0.25	0.24	0.04	-0.17	-0.09	-0.17	0.40	-0.13
Surprise	12.90%	-6.06%	60.00%	-50.00%	33.33%	50.00%	-173.33%	-227.27%	-533.33%	-266.67%	220.00%	0.00%	-81.58%	-51.85%	-10.71%	-14.29%	-84.62%	-170.83%	-	-	-	-
Timing	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	After-hours	Pre-market	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	Pre-market	After-hours

Key Statistics & Ratios

Market Cap6.48B

Enterprise Value4.10B

Trailing P/E6.33

Forward P/E0.00

Price / Sales5.78

Price / Book1.49

EPS3.09

Book Value13.25

Revenue (TTM)1.12B

Gross Profit (TTM)375.08M

EBITDA177.11M

Profit Margin91.92%

Operating Margin5.53%

Return on Equity25.70%

Return on Assets1.46%

Shares Outstanding331.55M

Shares Float269.71M

Beta0.13

Dividend Yield4.12%

Dividend Rate0.80

Payout Ratio12.39%

Dividends

20261×

0.80Jul 28, 2026

20251×

0.38Jul 14, 2025

20241×

0.08Jul 12, 2024

20231×

0.10Jul 6, 2023

20211×

0.12Sep 2, 2021

Stock Splits

Jul 28, 20261068:1000
Sep 2, 20211053.198:1000